Effects of the Oral Contraceptive Combination 0.150 mg Desogestrel+0.020 mg Ethinylestradiol on Serum Lipids, SHBG, Glycosylated Proteins and Plasma Antithrombin III Activity in Healthy Women
- 11 January 1987
- journal article
- Published by Wiley in Acta Obstetricia et Gynecologica Scandinavica
- Vol. 66 (S143), 37-39
- https://doi.org/10.3109/00016348709156494
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- On the use of Plasma Proteins as Indicators of the Metabolic Effects of Combined Oral ContraceptivesPublished by Wiley ,1982
- High density lipoprotein cholesterol and apolipoprotein A-I levels in 32–33-year-old women on steroid contraceptives—differences between two frequently used low-estrogen pillsClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Antithrombin III: Referenzwerte mit einem chromogenen Substrat (Chromozym TH)Blut: Zeitschrift für die Gesamte Blutforschung, 1981
- Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen bindingScandinavian Journal of Clinical and Laboratory Investigation, 1981
- Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations.BMJ, 1980
- High and Low High-Density Lipoproteins: Clinical ImplicationsAnnals of Nutrition and Metabolism, 1980
- SEX HORMONE BINDING GLOBULIN CAPACITY AS AN INDEX OF OESTROGENICITY OR ANDROGENICITY IN WOMEN ON ORAL CONTRACEPTIVE STEROIDSClinical Endocrinology, 1979
- A filter assay for the sex steroid binding protein (SBP) of human serumFEBS Letters, 1974